Marieta Toma

10PUBLICATIONS
106CO-AUTHORS
Predictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)Ngā mātauranga taiao o te Māori (Māori environmental knowledges)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 04, 2026
The Prognostic Impact of the Ki-67 Proliferation Index in Patients with Surgically Treated Spinal Metastases.

|Jul 09, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Jun 13, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Aug 29, 2024
Melanoma Brain Metastases Patient-Derived Organoids: An In Vitro Platform for Drug Screening.

Saif-Eldin Abedellatif, Racha Hosni, Andreas Waha

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

|Jan 04, 2024
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma.

Sana Hosni, Viola Kilian, Niklas Klümper

Pageof 2

Frequent Collaborators

6 joint publications

Niklas Klümper

5 joint publications

Michael Hölzel

5 joint publications

Glen Kristiansen

4 joint publications

Abdullah Alajati